Theodrenaline
WikiDoc Resources for Theodrenaline |
Articles |
---|
Most recent articles on Theodrenaline Most cited articles on Theodrenaline |
Media |
Powerpoint slides on Theodrenaline |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Theodrenaline at Clinical Trials.gov Trial results on Theodrenaline Clinical Trials on Theodrenaline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Theodrenaline NICE Guidance on Theodrenaline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Theodrenaline Discussion groups on Theodrenaline Patient Handouts on Theodrenaline Directions to Hospitals Treating Theodrenaline Risk calculators and risk factors for Theodrenaline
|
Healthcare Provider Resources |
Causes & Risk Factors for Theodrenaline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Theodrenaline (INN), also known as noradrenalinoethyltheophylline, is a chemical linkage of norepinephrine (noradrenaline) and theophylline used as a cardiac stimulant.
It is sometimes combined with cafedrine.[1]
See also
References
- ↑ Usichenko TI; Foellner S; Gruendling M; et al. (March 2006). "Akrinor-induced relaxation of pig coronary artery in vitro is transformed into alpha1-adrenoreceptor-mediated contraction by pretreatment with propranolol". J. Cardiovasc. Pharmacol. 47 (3): 450–5. doi:10.1097/01.fjc.0000211710.87863.89. PMID 16633089. Unknown parameter
|author-separator=
ignored (help)